Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.
Identifieur interne : 000B48 ( Ncbi/Curation ); précédent : 000B47; suivant : 000B49Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.
Auteurs : Donald R. Hopkins [États-Unis] ; Abel Eigege ; Emmanuel S. Miri ; Ibrahim Gontor ; Gladys Ogah ; John Umaru ; Chuwang C. Gwomkudu ; Wanjira Mathai ; My Jinadu ; Stanley Amadiegwu ; O Kehinde Oyenekan ; Kenneth Korve ; Frank O. RichardsSource :
- The American journal of tropical medicine and hygiene [ 0002-9637 ] ; 2002.
Descripteurs français
- KwdFr :
- Antihelminthiques (usage thérapeutique), Connaissances, attitudes et pratiques en santé, Filariose lymphatique (), Filariose lymphatique (épidémiologie), Humains, Nigeria (épidémiologie), Onchocercose (), Onchocercose (épidémiologie), Praziquantel (usage thérapeutique), Schistosomiase (), Schistosomiase (épidémiologie), Éducation pour la santé.
- MESH :
- usage thérapeutique : Antihelminthiques, Praziquantel.
- épidémiologie : Filariose lymphatique, Nigeria, Onchocercose, Schistosomiase.
- Connaissances, attitudes et pratiques en santé, Filariose lymphatique, Humains, Onchocercose, Schistosomiase, Éducation pour la santé.
- Wicri :
- geographic : Nigeria.
English descriptors
- KwdEn :
- Anthelmintics (therapeutic use), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Health Education, Health Knowledge, Attitudes, Practice, Humans, Nigeria (epidemiology), Onchocerciasis (epidemiology), Onchocerciasis (prevention & control), Praziquantel (therapeutic use), Schistosomiasis (epidemiology), Schistosomiasis (prevention & control).
- MESH :
- chemical , therapeutic use : Anthelmintics, Praziquantel.
- geographic , epidemiology : Nigeria.
- epidemiology : Elephantiasis, Filarial, Onchocerciasis, Schistosomiasis.
- prevention & control : Elephantiasis, Filarial, Onchocerciasis, Schistosomiasis.
- Health Education, Health Knowledge, Attitudes, Practice, Humans.
Abstract
This paper describes a pilot initiative to incorporate lymphatic filariasis (LF) elimination and urinary schistosomiasis (SH) control into a mature onchocerciasis control program based on community-directed ivermectin treatment in central Nigeria. In the same districts having onchocerciasis we found LF (as determined by blood antigen testing in adult males) in 90% of 149 villages with a mean prevalence of 22.4% (range 0-67%). Similarly, SH, as determined by dipstick reagent testing for blood in urine from school children, was found in 91% of 176 villages with a mean orevalence in school age children of 24.4% (range 0-87%). Health education and treatment interventions for SH resulted in 52,480 cumulative praziquantel treatments, and 159,555 combined onchocerciasis and LF treatments (with ivermectin and albendazole) as of the end of 2000. Treatments for onchocerciasis and LF were separated by at least 1 week from treatments for SH. There was no negative impact on the coverage of the onchocerciasis program by the addition of LF and SH activities.
PubMed: 12408665
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004442
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :004442
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :004442
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000B48
Links to Exploration step
pubmed:12408665Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.</title><author><name sortKey="Hopkins, Donald R" sort="Hopkins, Donald R" uniqKey="Hopkins D" first="Donald R" last="Hopkins">Donald R. Hopkins</name><affiliation wicri:level="1"><nlm:affiliation>The Carter Center, Atlanta, Georgia 30307, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Carter Center, Atlanta, Georgia 30307</wicri:regionArea><wicri:noRegion>Georgia 30307</wicri:noRegion></affiliation></author><author><name sortKey="Eigege, Abel" sort="Eigege, Abel" uniqKey="Eigege A" first="Abel" last="Eigege">Abel Eigege</name></author><author><name sortKey="Miri, Emmanuel S" sort="Miri, Emmanuel S" uniqKey="Miri E" first="Emmanuel S" last="Miri">Emmanuel S. Miri</name></author><author><name sortKey="Gontor, Ibrahim" sort="Gontor, Ibrahim" uniqKey="Gontor I" first="Ibrahim" last="Gontor">Ibrahim Gontor</name></author><author><name sortKey="Ogah, Gladys" sort="Ogah, Gladys" uniqKey="Ogah G" first="Gladys" last="Ogah">Gladys Ogah</name></author><author><name sortKey="Umaru, John" sort="Umaru, John" uniqKey="Umaru J" first="John" last="Umaru">John Umaru</name></author><author><name sortKey="Gwomkudu, Chuwang C" sort="Gwomkudu, Chuwang C" uniqKey="Gwomkudu C" first="Chuwang C" last="Gwomkudu">Chuwang C. Gwomkudu</name></author><author><name sortKey="Mathai, Wanjira" sort="Mathai, Wanjira" uniqKey="Mathai W" first="Wanjira" last="Mathai">Wanjira Mathai</name></author><author><name sortKey="Jinadu, My" sort="Jinadu, My" uniqKey="Jinadu M" first="My" last="Jinadu">My Jinadu</name></author><author><name sortKey="Amadiegwu, Stanley" sort="Amadiegwu, Stanley" uniqKey="Amadiegwu S" first="Stanley" last="Amadiegwu">Stanley Amadiegwu</name></author><author><name sortKey="Oyenekan, O Kehinde" sort="Oyenekan, O Kehinde" uniqKey="Oyenekan O" first="O Kehinde" last="Oyenekan">O Kehinde Oyenekan</name></author><author><name sortKey="Korve, Kenneth" sort="Korve, Kenneth" uniqKey="Korve K" first="Kenneth" last="Korve">Kenneth Korve</name></author><author><name sortKey="Richards, Frank O" sort="Richards, Frank O" uniqKey="Richards F" first="Frank O" last="Richards">Frank O. Richards</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12408665</idno><idno type="pmid">12408665</idno><idno type="wicri:Area/PubMed/Corpus">004442</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004442</idno><idno type="wicri:Area/PubMed/Curation">004442</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004442</idno><idno type="wicri:Area/PubMed/Checkpoint">004442</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004442</idno><idno type="wicri:Area/Ncbi/Merge">000B48</idno><idno type="wicri:Area/Ncbi/Curation">000B48</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.</title><author><name sortKey="Hopkins, Donald R" sort="Hopkins, Donald R" uniqKey="Hopkins D" first="Donald R" last="Hopkins">Donald R. Hopkins</name><affiliation wicri:level="1"><nlm:affiliation>The Carter Center, Atlanta, Georgia 30307, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The Carter Center, Atlanta, Georgia 30307</wicri:regionArea><wicri:noRegion>Georgia 30307</wicri:noRegion></affiliation></author><author><name sortKey="Eigege, Abel" sort="Eigege, Abel" uniqKey="Eigege A" first="Abel" last="Eigege">Abel Eigege</name></author><author><name sortKey="Miri, Emmanuel S" sort="Miri, Emmanuel S" uniqKey="Miri E" first="Emmanuel S" last="Miri">Emmanuel S. Miri</name></author><author><name sortKey="Gontor, Ibrahim" sort="Gontor, Ibrahim" uniqKey="Gontor I" first="Ibrahim" last="Gontor">Ibrahim Gontor</name></author><author><name sortKey="Ogah, Gladys" sort="Ogah, Gladys" uniqKey="Ogah G" first="Gladys" last="Ogah">Gladys Ogah</name></author><author><name sortKey="Umaru, John" sort="Umaru, John" uniqKey="Umaru J" first="John" last="Umaru">John Umaru</name></author><author><name sortKey="Gwomkudu, Chuwang C" sort="Gwomkudu, Chuwang C" uniqKey="Gwomkudu C" first="Chuwang C" last="Gwomkudu">Chuwang C. Gwomkudu</name></author><author><name sortKey="Mathai, Wanjira" sort="Mathai, Wanjira" uniqKey="Mathai W" first="Wanjira" last="Mathai">Wanjira Mathai</name></author><author><name sortKey="Jinadu, My" sort="Jinadu, My" uniqKey="Jinadu M" first="My" last="Jinadu">My Jinadu</name></author><author><name sortKey="Amadiegwu, Stanley" sort="Amadiegwu, Stanley" uniqKey="Amadiegwu S" first="Stanley" last="Amadiegwu">Stanley Amadiegwu</name></author><author><name sortKey="Oyenekan, O Kehinde" sort="Oyenekan, O Kehinde" uniqKey="Oyenekan O" first="O Kehinde" last="Oyenekan">O Kehinde Oyenekan</name></author><author><name sortKey="Korve, Kenneth" sort="Korve, Kenneth" uniqKey="Korve K" first="Kenneth" last="Korve">Kenneth Korve</name></author><author><name sortKey="Richards, Frank O" sort="Richards, Frank O" uniqKey="Richards F" first="Frank O" last="Richards">Frank O. Richards</name></author></analytic><series><title level="j">The American journal of tropical medicine and hygiene</title><idno type="ISSN">0002-9637</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anthelmintics (therapeutic use)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Health Education</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Nigeria (epidemiology)</term><term>Onchocerciasis (epidemiology)</term><term>Onchocerciasis (prevention & control)</term><term>Praziquantel (therapeutic use)</term><term>Schistosomiasis (epidemiology)</term><term>Schistosomiasis (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antihelminthiques (usage thérapeutique)</term><term>Connaissances, attitudes et pratiques en santé</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Nigeria (épidémiologie)</term><term>Onchocercose ()</term><term>Onchocercose (épidémiologie)</term><term>Praziquantel (usage thérapeutique)</term><term>Schistosomiase ()</term><term>Schistosomiase (épidémiologie)</term><term>Éducation pour la santé</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anthelmintics</term><term>Praziquantel</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Nigeria</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Onchocerciasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Onchocerciasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihelminthiques</term><term>Praziquantel</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Nigeria</term><term>Onchocercose</term><term>Schistosomiase</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Health Education</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Connaissances, attitudes et pratiques en santé</term><term>Filariose lymphatique</term><term>Humains</term><term>Onchocercose</term><term>Schistosomiase</term><term>Éducation pour la santé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Nigeria</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This paper describes a pilot initiative to incorporate lymphatic filariasis (LF) elimination and urinary schistosomiasis (SH) control into a mature onchocerciasis control program based on community-directed ivermectin treatment in central Nigeria. In the same districts having onchocerciasis we found LF (as determined by blood antigen testing in adult males) in 90% of 149 villages with a mean prevalence of 22.4% (range 0-67%). Similarly, SH, as determined by dipstick reagent testing for blood in urine from school children, was found in 91% of 176 villages with a mean orevalence in school age children of 24.4% (range 0-87%). Health education and treatment interventions for SH resulted in 52,480 cumulative praziquantel treatments, and 159,555 combined onchocerciasis and LF treatments (with ivermectin and albendazole) as of the end of 2000. Treatments for onchocerciasis and LF were separated by at least 1 week from treatments for SH. There was no negative impact on the coverage of the onchocerciasis program by the addition of LF and SH activities.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B48 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000B48 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:12408665
|texte= Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:12408665" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |